Cargando…

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis

Even if the incidence of tuberculosis (TB) has been decreasing over the last years, the number of patients with TB is increasing worldwide. The emergence of multidrug-resistant and extensively drug-resistant TB is making control of TB more difficult. Mycobacterium bovis bacillus Calmette–Guérin vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	La Manna, Marco P., Orlando, Valentina, Tamburini, Bartolo, Badami, Giusto D., Dieli, Francesco, Caccamo, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497315/ https://www.ncbi.nlm.nih.gov/pubmed/33013888 http://dx.doi.org/10.3389/fimmu.2020.02107

Ejemplares similares

Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8(+) T Cells
por: La Manna, Marco Pio, et al.
Publicado: (2022)

Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
por: Tamburini, Bartolo, et al.
Publicado: (2023)

Mycobacterium tuberculosis Drives Expansion of Low-Density Neutrophils Equipped With Regulatory Activities
por: La Manna, Marco Pio, et al.
Publicado: (2019)

Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease
por: Tamburini, Bartolo, et al.
Publicado: (2022)

Platelets accumulate in lung lesions of tuberculosis patients and inhibit T‐cell responses and Mycobacterium tuberculosis replication in macrophages
por: La Manna, Marco P., et al.
Publicado: (2022)

Impact of Mycobacterium tuberculosis Infection on Human B Cell Compartment and Antibody Responses
por: La Manna, Marco P., et al.
Publicado: (2022)

Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity
por: Mohammadnezhad, Leila, et al.
Publicado: (2022)

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis
por: Prezzemolo, Teresa, et al.
Publicado: (2014)

A Rapid and Simple Multiparameter Assay to Quantify Spike-Specific CD4 and CD8 T Cells after SARS-CoV-2 Vaccination: A Preliminary Report
por: Shekarkar Azgomi, Mojtaba, et al.
Publicado: (2021)

Correction: Shekarkar Azgomi et al. A Rapid and Simple Multiparameter Assay to Quantify Spike-Specific CD4 and CD8 T Cells after SARS-CoV-2 Vaccination: A Preliminary Report. Biomedicines 2021, 9, 1576
por: Shekarkar Azgomi, Mojtaba, et al.
Publicado: (2023)

Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During Mycobacterium Tuberculosis Infection and Correlate With Active Disease
por: Orlando, Valentina, et al.
Publicado: (2018)

Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease
por: La Manna, Marco Pio, et al.
Publicado: (2018)

Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells
por: Presti, Elena Lo, et al.
Publicado: (2016)

Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages
por: La Manna, Marco Pio, et al.
Publicado: (2017)

Atypical Human Effector/Memory CD4(+) T Cells With a Naive-Like Phenotype
por: Caccamo, Nadia, et al.
Publicado: (2018)

Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants
por: Willows, Steven, et al.
Publicado: (2020)

IL-21 Regulates the Differentiation of a Human γδ T Cell Subset Equipped with B Cell Helper Activity
por: Caccamo, Nadia, et al.
Publicado: (2012)

Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
por: Todaro, Matilde, et al.
Publicado: (2013)

Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy
por: Allegra, Alessandro, et al.
Publicado: (2022)

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
por: Lo Presti, Elena, et al.
Publicado: (2018)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Downregulation of miRNA17–92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis
por: Guggino, Giuliana, et al.
Publicado: (2018)

B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma
por: Mohammadnezhad, Leila, et al.
Publicado: (2023)

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
por: Lam, Pui Yeng, et al.
Publicado: (2017)

Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity
por: Todaro, Matilde, et al.
Publicado: (2013)

Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021)

Retraction: Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges
Publicado: (2023)

Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy
por: Tullett, Kirsteen M., et al.
Publicado: (2014)

Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy
por: Miao, Keyan, et al.
Publicado: (2023)

The promiscuous development of an unconventional Qa1b-restricted T cell population
por: Manoharan Valerio, Michael, et al.
Publicado: (2023)

Development of Unconventional T Cells Controlled by MicroRNA
por: Winter, Samantha J., et al.
Publicado: (2019)

Unconventional T cells in brain homeostasis, injury and neurodegeneration
por: Lv, Mengfei, et al.
Publicado: (2023)

Alkaline Phosphatase, an Unconventional Immune Protein
por: Rader, Bethany A.
Publicado: (2017)

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
por: Jiang, Jingyu, et al.
Publicado: (2023)

Maintenance of Barrier Tissue Integrity by Unconventional Lymphocytes
por: Cox, Joshua R., et al.
Publicado: (2021)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review
por: Chen, Xiao-Yang, et al.
Publicado: (2022)

MHC Class II Auto-Antigen Presentation is Unconventional
por: Sadegh-Nasseri, Scheherazade, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ncpir47qrf7bhos93tov1ke99o